STE实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	306 277
平均成交量	488 947
市值	20.15B
EPS	$0 ( 2024-02-07 )
下一个收益日期	( $2.43 ) 2024-05-08
Last Dividend	$0.520 ( 2023-11-20 )
Next Dividend	$0 ( N/A )
P/E	35.83
ATR14	$0.119 (0.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-22	Kohler Kenneth E	Sell	0	Ordinary Shares
2024-02-22	Kohler Kenneth E	Sell	2 136	Employee Stock Options (right to buy)
2024-02-22	Kohler Kenneth E	Sell	3 728	Employee Stock Options (right to buy)
2024-02-22	Kohler Kenneth E	Sell	2 764	Employee Stock Options (right to buy)
2024-02-22	Kohler Kenneth E	Sell	4 100	Employee Stock Options (right to buy)

INSIDER POWER
54.13
Last 98 transactions
Buy: 253 331 \| Sell: 67 940

音量相关性

長: 0.27 (neutral)

短: -0.93 (very strong negative)

Signal:(40.213) Neutral

Steris plc 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Steris plc 相关性 - 货币/商品

-0.48
( neutral )

-0.26
( neutral )

0.00
( neutral )

-0.66
( moderate negative )

0.06
( neutral )

0.47
( neutral )

Steris plc 财务报表

Annual	2023
营收:	$4.96B
毛利润:	$2.16B (43.56 %)
EPS:	$1.070

FY	2023
营收:	$4.96B
毛利润:	$2.16B (43.56 %)
EPS:	$1.070

FY	2022
营收:	$4.59B
毛利润:	$2.02B (43.98 %)
EPS:	$2.50

FY	2021
营收:	$3.11B
毛利润:	$1.34B (43.22 %)
EPS:	$4.66

Financial Reports:

No articles found.

Steris plc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.470 (N/A)	$0.470 (N/A)	$0.470 (N/A)	$0.470 (N/A)	$0.520 (N/A)	$0.520 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Steris plc Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.44 - Stable (11.29%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0400	2005-05-26
Last Dividend	$0.520	2023-11-20
Next Dividend	$0	N/A
Payout Date	2023-12-21
Next Payout Date	N/A
# dividends	75	--
Total Paid Out	$19.66	--
Avg. Dividend % Per Year	0.62%	--
Score	4.85	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.44
Div. Directional Score	7.86	--

Next Divdend (Est)
(2024-07-01)

$0.529 Estimate 39.86 %

Dividend Stability

0.80 Good

Dividend Score

4.85

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2005	$0.120	0.52%
2006	$0.170	0.67%
2007	$0.220	0.86%
2008	$0.280	0.97%
2009	$2.41	10.10%
2010	$0.520	1.84%
2011	$0.640	1.73%
2012	$0.720	2.39%
2013	$0.800	2.28%
2014	$0.880	1.86%
2015	$0.960	1.47%
2016	$1.060	1.43%
2017	$1.180	1.73%
2018	$1.300	1.47%
2019	$1.420	1.36%
2020	$1.540	1.02%
2021	$1.660	0.88%
2022	$1.800	0.74%
2023	$1.980	1.07%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
KIO	Dividend Royal	2023-12-14	Monthly	12	7.05%	8.50
NCZ	Dividend Royal	2024-02-09	Monthly	22	7.79%	8.50
SCM	Dividend King	2023-12-15	Monthly	13	7.08%	8.50
SJT	Dividend Royal	2023-11-29	Monthly	39	12.52%	8.50
GOF	Dividend Royal	2023-11-14	Monthly	18	8.03%	8.50
SRV	Dividend Royal	2023-12-04	Monthly	18	7.53%	8.50
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.105	1.500	7.90	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0496	1.200	8.35	10.00	[0 - 0.3]
returnOnEquityTTM	0.0912	1.500	-0.0981	-0.147	[0.1 - 1]
payoutRatioTTM	0.345	-1.000	6.55	-6.55	[0 - 1]
currentRatioTTM	2.43	0.800	2.86	2.29	[1 - 3]
quickRatioTTM	1.269	0.800	7.24	5.79	[0.8 - 2.5]
cashRatioTTM	0.214	1.500	9.92	10.00	[0.2 - 2]
debtRatioTTM	0.307	-1.500	4.89	-7.33	[0 - 0.6]
interestCoverageTTM	5.90	1.000	8.92	8.92	[3 - 30]
operatingCashFlowPerShareTTM	9.46	2.00	6.85	10.00	[0 - 30]
freeCashFlowPerShareTTM	6.01	2.00	6.99	10.00	[0 - 20]
debtEquityRatioTTM	0.547	-1.500	7.81	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.436	1.000	6.07	6.07	[0.2 - 0.8]
operatingProfitMarginTTM	0.151	1.000	8.98	8.98	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.266	1.000	9.63	9.63	[0.2 - 2]
assetTurnoverTTM	0.473	0.800	-0.181	-0.145	[0.5 - 2]
Total Score				11.28

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	35.54	1.000	6.51	0	[1 - 100]
returnOnEquityTTM	0.0912	2.50	-0.0631	-0.147	[0.1 - 1.5]
freeCashFlowPerShareTTM	6.01	2.00	8.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.996	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	9.46	2.00	6.85	10.00	[0 - 30]
payoutRatioTTM	0.345	1.500	6.55	-6.55	[0 - 1]
pegRatioTTM	-0.621	1.500	-7.48	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.173	1.000	8.18	0	[0.1 - 0.5]
Total Score				4.44

Steris plc

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.